These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9489296)

  • 1. A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization.
    Yoshikawa A; Saura R; Matsubara T; Mizuno K
    Kobe J Med Sci; 1997 Aug; 43(3-4):109-20. PubMed ID: 9489296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L; Davis R; Anwar A; Behbakht K
    Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
    Bian F; Zhang MC; Zhu Y
    Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
    Li D; Williams JI; Pietras RJ
    Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.
    Benelli U; Bocci G; Danesi R; Lepri A; Bernardini N; Bianchi F; Lupetti M; Dolfi A; Campagni A; Agen C; Nardi M; Del Tacca M
    Exp Eye Res; 1998 Aug; 67(2):133-42. PubMed ID: 9733580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
    Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of melatonin on the proliferation and cis-diamminedichloroplatinum (CDDP) sensitivity of cultured human ovarian cancer cells.
    Futagami M; Sato S; Sakamoto T; Yokoyama Y; Saito Y
    Gynecol Oncol; 2001 Sep; 82(3):544-9. PubMed ID: 11520153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
    Spugnini EP; Cardillo I; Verdina A; Crispi S; Saviozzi S; Calogero R; Nebbioso A; Altucci L; Cortese G; Galati R; Chien J; Shridhar V; Vincenzi B; Citro G; Cognetti F; Sacchi A; Baldi A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6133-43. PubMed ID: 17062690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of growth-inhibitory effect of cisplatin on human pancreatic cancer cells and status of p53 gene.
    Seki T; Ohba N; Makino R; Funatomi H; Mitamura K
    Anticancer Res; 2001; 21(3B):1919-24. PubMed ID: 11497278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T; Saura R; Hirohata K; Ziff M
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.
    Ito M; Yamamoto S; Nimura K; Hiraoka K; Tamai K; Kaneda Y
    J Gene Med; 2005 Aug; 7(8):1044-52. PubMed ID: 15756713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells.
    Zhong XS; Liu LZ; Skinner HD; Cao Z; Ding M; Jiang BH
    Biochem Biophys Res Commun; 2007 Jun; 358(1):92-8. PubMed ID: 17470361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel formulation of cisplatin (CDDP)].
    Sugitachi A; Kimura Y; Itabashi T; Noda H; Ishida K; Nishizuka S; Otsuka K; Kashiwaba M; Nitta H; Koeda K; Mizuno M; Sasaki A; Ikeda K; Takamori Y; Wakabayashi G
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2294-6. PubMed ID: 20037400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature.
    Sills AK; Williams JI; Tyler BM; Epstein DS; Sipos EP; Davis JD; McLane MP; Pitchford S; Cheshire K; Gannon FH; Kinney WA; Chao TL; Donowitz M; Laterra J; Zasloff M; Brem H
    Cancer Res; 1998 Jul; 58(13):2784-92. PubMed ID: 9661892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.